Erratum: Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of experimental & clinical cancer research : CR (2019) 38 1 (474))

Ssu Chuan Lai, Yu Ting Su, Ching Chi Chi, Yung Che Kuo, Kam Fai Lee, Yu Chih Wu, Pei Chi Lan, Muh Hwa Yang, Te Sheng Chang, Yen Hua Huang

研究成果: 雜誌貢獻評論/辯論

摘要

In the original publication of this article [1], labelling within Fig. 7a was incorrect. The updated figure is shown below, with 'DMT1' now corrected to read 'DNMT1'.
原文英語
頁數1
期刊Journal of experimental & clinical cancer research : CR
39
發行號1
DOIs
出版狀態已發佈 - 一月 13 2020

    指紋

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

引用此